Novo Nordisk A/S
NONOF
$47.49
-$1.18-2.42%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.46% | 6.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.46% | 6.14% | |||
| Cost of Revenue | 16.01% | 7.47% | |||
| Gross Profit | -2.66% | 5.87% | |||
| SG&A Expenses | -13.89% | 26.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | 277.15% | |||
| Total Operating Expenses | -1.02% | 19.12% | |||
| Operating Income | 2.38% | -7.02% | |||
| Income Before Tax | -22.27% | -1.57% | |||
| Income Tax Expenses | -22.28% | -1.56% | |||
| Earnings from Continuing Operations | -22.26% | -1.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -22.26% | -1.57% | |||
| EBIT | 2.38% | -7.02% | |||
| EBITDA | -0.18% | -4.75% | |||
| EPS Basic | -22.26% | -1.65% | |||
| Normalized Basic EPS | 6.89% | -1.65% | |||
| EPS Diluted | -22.25% | -1.57% | |||
| Normalized Diluted EPS | 6.88% | -1.57% | |||
| Average Basic Shares Outstanding | 0.00% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.01% | |||
| Dividend Per Share | -100.00% | -- | |||
| Payout Ratio | -- | -- | |||